D-0921-2023 Class I Ongoing

Recalled by Global Pharma Healthcare Private Limited — Chennai, N/A

FDA drug recall D-0921-2023 was initiated by Global Pharma Healthcare Private Limited on Jan 30, 2023 and is designated Class I. Reason for recall: Non-Sterility: FDA analysis found unopened products to have bacterial contamination. The recall status is ongoing. Affected quantity: 400,008 bottles total for all products.

Recall details

Product Type
Drugs
Report Date
Jul 19, 2023
Initiation Date
Jan 30, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
400,008 bottles total for all products

Product description

Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.

Reason for recall

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Distribution pattern

Product was distributed to two distributors who further distributed Nationwide in the USA.

Code information

Lot #: PCMH001, PCMH002, PCMH005, PCMH007, Exp. date NOV-2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0921-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0921-2023. Report a data issue: hello@regdatalab.com.